Healthcare costs continue to rise, and the explanation most people hear is simple:
“It’s inflation.”
Certainly, inflation plays a role. Healthcare organizations face higher labor costs, rising supply expenses, and increasing operational costs just like every other industry.
But if inflation were the whole story, healthcare spending would rise at roughly the same pace across the board.
That’s not what’s happening.
The reality is that some areas of healthcare are becoming dramatically more expensive than others, revealing a more complicated set of forces at work beneath the surface.
Not All Healthcare Costs Are Rising Equally
According to PwC’s latest Medical Cost Trend report, employer-sponsored healthcare costs are projected to increase by 8.5% in 2026, one of the highest increases in years.
Yet those increases are not being driven equally across all services.
Much of today’s cost growth is concentrated in specialty medications, behavioral health services, outpatient care, and high-cost pharmaceutical treatments. In other words, healthcare spending isn’t simply growing—it’s shifting toward some of the most expensive areas of the system.
This distinction matters because it changes the conversation from “Healthcare is getting more expensive” to “Which parts of healthcare are getting more expensive, and why?”
Prescription Drugs Are Reshaping Healthcare Spending
For decades, hospitals and physician services represented the largest drivers of healthcare costs.
While they remain significant contributors, pharmacy spending has become one of the fastest-growing categories in healthcare.
New specialty medications, gene therapies, and GLP-1 drugs for weight loss and diabetes are producing remarkable clinical outcomes. They’re also introducing costs that many health plans and patients were not built to absorb.
At the same time, drug pricing remains extraordinarily complex.
Between manufacturers, wholesalers, pharmacies, and pharmacy benefit managers, multiple entities influence what ultimately gets paid. For consumers, the process is often invisible. For employers and health plans, it can be difficult to determine where costs are actually originating.
More Care Isn’t Always the Same as Better Care
Another factor driving spending is utilization.
Following years of delayed screenings, postponed procedures, and deferred care, more people are seeking treatment that was previously put on hold.
In many cases, that’s a positive development.
But increased utilization naturally leads to higher spending, particularly when care occurs later in the progression of a condition. A preventive visit is far less expensive than a hospitalization. A routine screening is less costly than advanced treatment.
This is one reason healthcare affordability remains such a challenge despite improvements in medical technology and treatment options.
The Transparency Problem
Imagine purchasing a car, remodeling your kitchen, or hiring a contractor without knowing the price until weeks after the transaction.
That would seem absurd.
Yet that’s often how healthcare operates.
Patients frequently receive care without understanding what it will cost, how prices compare between providers, or why the same service can vary dramatically in price from one facility to another.
When pricing remains hidden, competition becomes less effective and consumers have fewer opportunities to make informed decisions.
Looking Beyond the Headline
Healthcare inflation is real.
But inflation alone cannot explain the complexity of rising healthcare costs.
Prescription drug spending, delayed care, increasing utilization, market consolidation, and limited transparency all contribute to the financial pressures facing patients, families, employers, and healthcare organizations alike.
The next time healthcare costs increase, the most important question may not be how much they rose.
It may be what actually caused them to rise.
Understanding that difference is often the first step toward understanding the healthcare system itself.